A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled "SAMP ...

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...

Modern cancer detection often depends on spotting tiny abnormalities in scans, something even trained specialists can miss.

BioMark Diagnostics ( ($TSE:BUX) ) has provided an announcement. BioMark Diagnostics Inc. and its research partners have been honored with the ...

A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...

"Skin cancer, particularly melanoma, is a disease in which early detection is critically important for determining survival rates," says Prof. Jeon. "Since melanoma is difficult to diagnose based ...

The partnership will expedite the availability of Freenome's tests in markets outside the U.S, according to the company.

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

ScreenPoint Medical today announced the completion of a commercial agreement making its Transpara® breast-imaging AI portfolio available through Precision Imaging Network, part of Microsoft for ...